Published in Invest Ophthalmol Vis Sci on August 01, 2005
Development of a training protocol to improve reading performance in peripheral vision. Vision Res (2010) 1.04
Eye movements during visual search in patients with glaucoma. BMC Ophthalmol (2012) 0.94
Characteristics of fixational eye movements in people with macular disease. Invest Ophthalmol Vis Sci (2014) 0.85
Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci (2014) 0.84
A study of eccentric viewing training for low vision rehabilitation. Korean J Ophthalmol (2011) 0.83
Functional and structural brain modifications induced by oculomotor training in patients with age-related macular degeneration. Front Psychol (2013) 0.82
Smooth pursuit eye movements in patients with macular degeneration. J Vis (2016) 0.81
Enhanced text spacing improves reading performance in individuals with macular disease. PLoS One (2013) 0.81
Characterization of field loss based on microperimetry is predictive of face recognition difficulties. Invest Ophthalmol Vis Sci (2014) 0.80
Reproducibility of activation maps for longitudinal studies of visual function by functional magnetic resonance imaging. Invest Ophthalmol Vis Sci (2012) 0.80
Random word recognition chart helps scotoma assessment in low vision. Optom Vis Sci (2015) 0.79
[Localization of scotomas in AMD by reading test : Random series of words in standardized format]. Ophthalmologe (2016) 0.76
Evaluation of a gaze-controlled vision enhancement system for reading in visually impaired people. PLoS One (2017) 0.75
fMRI evidence of improved visual function in patients with progressive retinitis pigmentosa by eye-movement training. Neuroimage Clin (2014) 0.75
Integrating oculomotor and perceptual training to induce a pseudofovea: A model system for studying central vision loss. J Vis (2016) 0.75
Training eye movements for visual search in individuals with macular degeneration. J Vis (2016) 0.75
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A (2008) 7.16
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol (2011) 3.79
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med (2011) 3.60
Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc Natl Acad Sci U S A (2005) 2.36
A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet (2002) 2.29
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol (2006) 2.27
Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2012) 2.26
Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing. Ophthalmology (2008) 2.14
Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease. Retina (2014) 1.99
Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet (2012) 1.96
Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci U S A (2005) 1.88
Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci (2011) 1.87
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol (2010) 1.85
Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology (2003) 1.69
Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci (2011) 1.61
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol (2010) 1.56
Identification of novel mutations in patients with Leber congenital amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP microarrays. Invest Ophthalmol Vis Sci (2007) 1.54
Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 1.47
Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J Med Genet (2013) 1.47
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol (2010) 1.46
The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral-domain optical coherence tomography. Ophthalmic Genet (2013) 1.45
Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity. Retina (2008) 1.45
Immunosuppression for autoimmune retinopathy. Arch Ophthalmol (2009) 1.43
Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology (2005) 1.43
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med (2017) 1.40
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res (2007) 1.37
Retinal nerve fiber layer analysis in RP patients using Fourier-domain OCT. Invest Ophthalmol Vis Sci (2008) 1.37
Retinal nerve fiber layer defects in RP patients. Invest Ophthalmol Vis Sci (2007) 1.36
Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. Ophthalmology (2010) 1.30
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat (2011) 1.28
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer. Cancer Res (2010) 1.27
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet (2013) 1.27
Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis. Invest Ophthalmol Vis Sci (2009) 1.24
Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina (2011) 1.24
Central serous chorioretinopathy associated with administration of sympathomimetic agents. Am J Ophthalmol (2003) 1.23
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. J Clin Invest (2010) 1.22
CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest Ophthalmol Vis Sci (2009) 1.21
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomas. J Immunol (2006) 1.20
Sequential multifocal electroretinogram findings in a case of Purtscher-like retinopathy. Am J Ophthalmol (2002) 1.18
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2. Clin Cancer Res (2009) 1.17
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse. Mol Ther (2013) 1.16
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer. Mol Ther (2008) 1.16
Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina (2005) 1.14
Use of dorzolamide for patients with X-linked retinoschisis. Retina (2006) 1.14
Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci (2004) 1.13
Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. J Glaucoma (2003) 1.12
Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology (2004) 1.10
Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet (2009) 1.10
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology (2003) 1.10
Improvement in visual function and fundus findings for a patient with vitamin A-deficient retinopathy. Retina (2005) 1.09
Retinal thickness and visual thresholds measured in patients with retinitis pigmentosa. Retina (2007) 1.09
Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas. Cancer Res (2009) 1.09
Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology (2002) 1.09
Use of prisms for navigation and driving in hemianopic patients. Ophthalmic Physiol Opt (2005) 1.08
Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Retina (2007) 1.06
Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Am J Ophthalmol (2008) 1.06
The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2009) 1.06
Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol (2008) 1.06
ON-pathway dysfunction and timing properties of the flicker ERG in carriers of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci (2003) 1.05
Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina (2012) 1.05
Autoimmune retinopathy and antiretinal antibodies: a review. Retina (2014) 1.04
Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol (2011) 1.04
Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. J Med Genet (2010) 1.02
Macular vitelliform lesion in desferrioxamine-related retinopathy. Doc Ophthalmol (2010) 1.02
Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci (2011) 1.02
Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease. Retina (2011) 1.01
Reading rehabilitation of individuals with AMD: relative effectiveness of training approaches. Invest Ophthalmol Vis Sci (2011) 1.01
Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease. Am J Ophthalmol (2012) 1.00
Use of Rasch person-item map in exploratory data analysis: a clinical perspective. J Rehabil Res Dev (2004) 1.00
The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina (2011) 1.00
Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci (2006) 0.99
Peripapillary retinal nerve fiber layer thinning in patients with autosomal recessive cone-rod dystrophy. Am J Ophthalmol (2009) 0.98
Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. Am J Ophthalmol (2003) 0.98
Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol (2010) 0.96
CRB1 gene mutations are associated with keratoconus in patients with leber congenital amaurosis. Invest Ophthalmol Vis Sci (2009) 0.96
A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction. Ophthalmology (2002) 0.96
A substitution of G to C in the cone cGMP-phosphodiesterase gamma subunit gene found in a distinctive form of cone dystrophy. Ophthalmology (2005) 0.96
Mutated alleles of the rod and cone Na-Ca+K-exchanger genes in patients with retinal diseases. Invest Ophthalmol Vis Sci (2002) 0.95
Intersession repeatability of humphrey perimetry measurements in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2007) 0.95
Microperimetry and OCT findings in female carriers of choroideremia. Ophthalmic Genet (2010) 0.95
Retinal dysfunction in carriers of bardet-biedl syndrome. Ophthalmic Genet (2007) 0.94
Contrast-processing deficits in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci (2004) 0.93
Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci (2002) 0.93
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy. Mol Ther (2011) 0.92
Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol (2013) 0.92
Multifocal electroretinography as a function of age: the importance of normative values for older adults. Invest Ophthalmol Vis Sci (2003) 0.91
Contrast sensitivity deficits in inferred magnocellular and parvocellular pathways in retinitis pigmentosa. Invest Ophthalmol Vis Sci (2004) 0.91
A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa. Ophthalmology (2004) 0.90
Atypical presentation of pattern dystrophy in two families with peripherin/RDS mutations. Ophthalmology (2002) 0.89
Automated measurement of blood flow velocity and direction and hemoglobin oxygen saturation in the rat lung using intravital microscopy. Am J Physiol Lung Cell Mol Physiol (2012) 0.89
CRB1 heterozygotes with regional retinal dysfunction: implications for genetic testing of leber congenital amaurosis. Invest Ophthalmol Vis Sci (2006) 0.89
Characteristics of contrast processing deficits in X-linked retinoschisis. Vision Res (2005) 0.88
Dorzolamide use in the management of macular cysts in a patient with enhanced s-cone syndrome. Retin Cases Brief Rep (2009) 0.87
Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet (2010) 0.87
Activation phase of cone phototransduction and the flicker electroretinogram in retinitis pigmentosa. Vision Res (2006) 0.87